跳至主要内容
临床试验/NCT06479668
NCT06479668已完成不适用

Characterize the Links Between Sleep, Emotional Dysregulation and Learning in Neurodevelopmental Disorders.

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年10月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
change micro-awakening index

研究概览

简要总结

The aim of this protocol is to disentangle the links between symptoms of emotion dysregulation, sleep disorders and cognitive deficits by measuring the effects of an emotional induction task on childrens' sleep with autism spectrum disorders (ASD) and attention deficit hyperactivity disorder (ADHD).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
7 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subjects aged 7 to 12
  • Able to receive clear, age-appropriate information and to participate fully in the study
  • Whose legal representative(s) are able to understand the objectives and risks of the research and to give their dated and signed informed consent.
  • Subjects benefiting from a social health insurance plan (beneficiary of the legal representative(s))
  • With a diagnosis made prior to inclusion of Autism Spectrum Disorder (ASD) or Attention Deficit Disorder with or without Hyperactivity (ADHD) as defined by Diagnostic and Statistical Manual 5 (DSM-5).
  • With abbreviated intelligence quotient > 80 measured by Wechsler Intelligence Scale for Children version IV (WISC-IV )no more than 6 months prior to research inclusion
  • No diagnosis of: fragile X syndrome, Rett syndrome, trisomy 21, tuberous sclerosis of Bourneville, von Recklinghausen disease, Cytomegalovirus encephalitis (CMV encephalitis), congenital rubella, phenylketonuria
  • No clinically significant abnormality which, in the investigator's opinion, could interfere with the implementation of the study.

排除标准

  • - Current or past neurological problem(s) (e.g. stroke, epilepsy, meningitis, head trauma with loss of consciousness of more than 15 min, concussion, brain tumor, ...).
  • tumor, ...)
  • Transmeridian travel (> 2 time zones) in the month prior to study inclusion
  • Presence of a mood disorder (bipolar disorder or depression) according to DSM-5 criteria
  • Social jet-lag > 2 hours (mid-point of sleep differential during weekends vs. weekdays)
  • Modification of psychotropic medication in the 2 months prior to inclusion
  • Use of melatonin-based dietary supplement(s)/medication(s) in the 24 hours prior to study inclusion
  • Use of psychostimulant(s) within 48 hours of study entry
  • Extreme chronotype (Morningness/Eveningness questionnaire score < 10 or > 42)
  • Cognitive-behavioral therapies (CBT) targeting sleep disorders
  • Participation in research involving an experimental drug which may interfere with the protocol*.
  • Minor under guardianship
  • Subject in a period of exclusion (determined by a previous or current study)
  • Subject in emergency situation

研究组 & 干预措施

Autism Spectrum Disorder

Experimental

干预措施: Trier Social Stress Task (Behavioral)

Attention Deficit Disorder with or without Hyperactivity

Experimental

干预措施: Trier Social Stress Task (Behavioral)

结局指标

主要结局

change micro-awakening index

时间窗: At Day 0 and Day 3

polysomnography

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验